{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:02:41Z","timestamp":1791018161891,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1136\/ard.2008.094714","type":"journal-article","created":{"date-parts":[[2008,10,29]],"date-time":"2008-10-29T02:05:46Z","timestamp":1225245946000},"page":"1564-1571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides"],"prefix":"10.1016","volume":"68","author":[{"given":"B","family":"Terrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"S\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ghillani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Deray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Fautrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-C","family":"Piette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2008.094714_bib1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)69114-9","article-title":"Antineutrophil cytoplasmic antibodies","volume":"368","author":"Bosch","year":"2006","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.094714_bib2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A","article-title":"Antineutrophil cytoplasmic antibodies","volume":"41","author":"Hoffman","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.094714_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1136\/ard.2008.094714_bib4","first-page":"S3","article-title":"Thoughts about the classification of small vessel vasculitis","volume":"17","author":"Falk","year":"2004","journal-title":"J Nephrol"},{"key":"10.1136\/ard.2008.094714_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/rheumatology\/41.5.481","article-title":"Rational use of ANCA in the diagnosis of vasculitis","volume":"41","author":"Wiik","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2008.094714_bib6","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1681\/ASN.2005101048","article-title":"Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies","volume":"17","author":"Jennette","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/ard.2008.094714_bib7","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1053\/j.ajkd.2005.01.001","article-title":"Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs","volume":"45","author":"Schlieben","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/ard.2008.094714_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1081-1206(10)61400-7","article-title":"Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement","volume":"93","author":"Bansal","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1136\/ard.2008.094714_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.ASN.0000050223.34749.F4","article-title":"Activation of the G(i) heterotrimeric G protein by ANCA IgG F(ab\u2032)2 fragments is necessary but not sufficient to stimulate the recruitment of those downstream mediators used by intact ANCA IgG","volume":"14","author":"Williams","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/ard.2008.094714_bib10","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.153.3.1271","article-title":"Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa","volume":"153","author":"Porges","year":"1994","journal-title":"J Immunol"},{"key":"10.1136\/ard.2008.094714_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jlb.50.6.539","article-title":"Antibodies against granule proteins activate neutrophils in vitro","volume":"50","author":"Charles","year":"1991","journal-title":"J Leukoc Biol"},{"key":"10.1136\/ard.2008.094714_bib12","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard.2008.094714_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1042\/CS20040232","article-title":"Translating basic science into patient therapy for ANCA-associated small vessel vasculitis","volume":"108","author":"Williams","year":"2005","journal-title":"Clin Sci (Lond)"},{"key":"10.1136\/ard.2008.094714_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1681\/ASN.V83386","article-title":"Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils","volume":"8","author":"Kettritz","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/ard.2008.094714_bib15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2249.1994.tb06137.x","article-title":"Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process","volume":"98","author":"Mulder","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2008.094714_bib16","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1002\/1529-0131(200112)44:12<2851::AID-ART473>3.0.CO;2-2","article-title":"Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells","volume":"44","author":"Radford","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.094714_bib17","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/1529-0131(200006)43:6<1337::AID-ANR16>3.0.CO;2-M","article-title":"Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion","volume":"43","author":"Radford","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.094714_bib18","first-page":"335","article-title":"Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells","volume":"141","author":"Savage","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.2008.094714_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ki.1992.52","article-title":"Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells","volume":"41","author":"Ewert","year":"1992","journal-title":"Kidney Int"},{"key":"10.1136\/ard.2008.094714_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1189\/jlb.1202611","article-title":"Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies","volume":"74","author":"Rarok","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1136\/ard.2008.094714_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9440(10)62952-5","article-title":"Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha","volume":"167","author":"Huugen","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.2008.094714_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9440(10)62951-3","article-title":"The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies","volume":"167","author":"Xiao","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.2008.094714_bib23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2008.094714_bib24","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1182\/blood-2005-03-0921","article-title":"Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo","volume":"106","author":"Little","year":"2005","journal-title":"Blood"},{"key":"10.1136\/ard.2008.094714_bib25","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2004-01-0267","article-title":"Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo","volume":"104","author":"Pfister","year":"2004","journal-title":"Blood"},{"key":"10.1136\/ard.2008.094714_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.2008.094714_bib27","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/art.22741","article-title":"Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis","volume":"56","author":"Guilpain","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.094714_bib28","first-page":"523","article-title":"Anti-neutrophil cytoplasmic antibodies: tools for diagnosis and follow-up in systemic vasculitis","volume":"145","author":"Stegeman","year":"1994","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1136\/ard.2008.094714_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/rheumatology\/40.2.147","article-title":"Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener\u2019s granulomatosis? A prospective study","volume":"40","author":"Girard","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2008.094714_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/ndt\/6.10.689","article-title":"Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis","volume":"6","author":"Gaskin","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/ard.2008.094714_bib31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0272-6386(95)90098-5","article-title":"Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis","volume":"25","author":"De\u2019Oliviera","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/ard.2008.094714_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9343(99)00064-9","article-title":"Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis","volume":"106","author":"Kyndt","year":"1999","journal-title":"Am J Med"},{"key":"10.1136\/ard.2008.094714_bib33","first-page":"127","article-title":"ANCA and predicting relapse in systemic vasculitis","volume":"88","author":"Jayne","year":"1995","journal-title":"Q J Med"},{"key":"10.1136\/ard.2008.094714_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener\u2019s granulomatosis","volume":"1","author":"van der Woude","year":"1985","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.094714_bib35","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","article-title":"Prediction of relapses in Wegener\u2019s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study","volume":"43","author":"Boomsma","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.094714_bib36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0140-6736(90)92205-V","article-title":"Prevention of relapses in Wegener\u2019s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre","volume":"336","author":"Tervaert","year":"1990","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.094714_bib37","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/archinte.1989.00390110055012","article-title":"Association between active Wegener\u2019s granulomatosis and anticytoplasmic antibodies","volume":"149","author":"Tervaert","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2008.094714_bib38","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/rheumatology\/kei272","article-title":"Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment","volume":"45","author":"Sanders","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2008.094714_bib39","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/ndt\/17.12.2077","article-title":"Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis","volume":"17","author":"Stegeman","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/ard.2008.094714_bib40","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-147-9-200711060-00005","article-title":"Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis","volume":"147","author":"Finkielman","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.094714_bib41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/art.1780360312","article-title":"Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener\u2019s granulomatosis","volume":"36","author":"Kerr","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.094714_bib42","doi-asserted-by":"crossref","first-page":"925","DOI":"10.7326\/0003-4819-123-12-199512150-00005","article-title":"The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis","volume":"123","author":"Rao","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.094714_bib43","first-page":"219","article-title":"Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study","volume":"37","author":"Pettersson","year":"1992","journal-title":"Clin Nephrol"},{"key":"10.1136\/ard.2008.094714_bib44","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/ndt\/14.7.1667","article-title":"Relationship between ANCA and disease activity in small vessel vasculitis patients with anti-MPO ANCA","volume":"14","author":"Ara","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/ard.2008.094714_bib45","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780330805","article-title":"The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa","volume":"33","author":"Lightfoot","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.094714_bib46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.094714_bib47","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.094714_bib48","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg\u2013Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.094714_bib49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.094714_bib50","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"Q J Med"},{"key":"10.1136\/ard.2008.094714_bib51","first-page":"31","article-title":"Development and validation of a disease extent index for Wegener\u2019s granulomatosis","volume":"55","author":"de Groot","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1136\/ard.2008.094714_bib52","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.094714_bib53","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-143-9-200511010-00005","article-title":"Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis","volume":"143","author":"Hogan","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.094714_bib54","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1523-1755.2003.00821.x","article-title":"Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis","volume":"63","author":"Han","year":"2003","journal-title":"Kidney Int"},{"key":"10.1136\/ard.2008.094714_bib55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for refractory Wegener\u2019s granulomatosis: report of a prospective, open-label pilot trial","volume":"173","author":"Keogh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1136\/ard.2008.094714_bib56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1196\/annals.1313.019","article-title":"Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis","volume":"1050","author":"Sinico","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1136\/ard.2008.094714_bib57","first-page":"479","article-title":"Anti-myeloperoxidase antibodies in patients with microscopic polyangiitis","volume":"57","author":"Pradhan","year":"2003","journal-title":"Indian J Med Sci"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724216228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724216228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2008.094714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T15:32:52Z","timestamp":1736091172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724216228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0003496724216228"],"URL":"https:\/\/doi.org\/10.1136\/ard.2008.094714","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2008.094714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Inc. Publishing Group Ltd and European League Against Rheumatism. All rights reserved. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}